All In Biotech

Drug Trial Radar · NCT07598825

A Trial of Inebilizumab in Participants With Autoimmune Hepatitis

A Phase 2/3, Randomized, Double-blind, Multicenter, Placebo-controlled Study of Inebilizumab in Participants With Autoimmune Hepatitis

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 180 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

180

Planned (sponsor's estimate)

Start

Dec 18, 2026

Primary completion

Jul 30, 2031

Study completion Feb 11, 2034

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
May 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objectives of this trial are to evaluate the safety and tolerability of inebilizumab in participants with autoimmune hepatitis (AIH) (Part 1) and to evaluate the efficacy of inebilizumab on AIH disease activity and glucocorticoid (GC) use in the management of AIH (Part 2).

Conditions

  • Autoimmune Hepatitis
  • AIH

Interventions

  • InebilizumabDrug

    Inebilizumab will be administered as an IV infusion.

  • PlaceboDrug

    Placebo will be administered as IV infusion.

  • Standard of CareOther

    Standard of Care

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part 1: Number of Participants who Experienced Treatment-emergent Adverse Events (TEAEs), Serious TEAEs, and TEAEs of Interest at Week 26Time frame: Up to Week 26
  2. Part 2: Number of Participants who Achieved Modified Histologic Activity Index (mHAI) ≤ 3 and Stable Prednisone Dose (or equivalent) ≤ 5 mg/day at Week 78Time frame: Week 78

Locations

36 sites in 8 countries. Site status is shown where the registry gives one.

  • Applied Research Center of Arkansas

    Little Rock, Arkansas · Recruiting

  • Inland Empire Liver Foundation

    Rialto, California · Recruiting

  • Amicis Research Center

    Valencia, California · Terminated

  • Mayo Clinic Jacksonville

    Jacksonville, Florida · Recruiting

  • Florida Research Institute

    Largo, Florida · Recruiting

  • Floridian Clinical Research LLC

    Miami Lakes, Florida · Recruiting

  • Indiana University

    Indianapolis, Indiana · Recruiting

  • Mayo Clinic Rochester

    Rochester, Minnesota · Recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania · Recruiting

  • Medical University of South Carolina

    Charleston, South Carolina · Recruiting

  • Methodist Cardiovascular Consultants - Dallas

    Dallas, Texas · Recruiting

  • American Research Corporation

    San Antonio, Texas · Recruiting

  • Universitair Ziekenhuis Leuven

    Leuven, Belgium · Recruiting

  • Centre de Recherche du Centre Hospitalier de l Universite de Montreal

    Montreal, Quebec, Canada · Recruiting

  • McGIll University Health Centre Glen Site

    Montreal, Quebec, Canada · Recruiting

  • The Second Hospital of Anhui Medical University

    Hefei, Anhui, China · Recruiting

  • Peking University First Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Beijing Friendship Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • Beijing Youan Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • The Second Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China · Recruiting

  • Mengchao Hepatobiliary Hospital of Fujian Medical University

    Fuzhou, Fujian, China · Recruiting

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China · Recruiting

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, Hubei, China · Recruiting

  • The Second Hospital of Nanjing

    Nanjing, Jiangsu, China · Recruiting

  • Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, China · Recruiting

  • The Fifth Peoples Hospital of Suzhou

    Suzhou, Jiangsu, China · Recruiting

  • The First Bethune Hospital of Jilin University

    Changchun, Jilin, China · Recruiting

  • Renji Hospital Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, China · Recruiting

  • West China Hospital Sichuan University

    Chengdu, Sichuan, China · Recruiting

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

  • Tianjin First Central Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

  • Hôpital Saint Antoine

    Paris, France · Recruiting

  • Universitaetsklinikum Jena

    Jena, Germany · Recruiting

  • Obudai Egeszsegugyi Centrum Kft

    Zalaegerszeg, Hungary · Recruiting

  • IRCCS Istituto Clinico Humanitas

    Rozzano, Italy · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.